Phenominer Database Results (15 results)

 
 
Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Site Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Clinical Measurement Notes Record ID Study ID
MWF/ZtmRrrc efferent colloid osmotic pressure enalapril (50 mg/l) (for 60 days) Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. blood molecular composition trait male 126.0 days 10 29.0 mmHg 0.95 3.0 servo-null micropipette transducer method renal efferent arteriole 0.0 100968 2541
MW efferent colloid osmotic pressure nephrectomy (for 28 days) then control condition Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. blood molecular composition trait male  days 8 32.0 mmHg 1.0 2.83 micropuncture fluid collection 0.0 5/6 nephrectomy 28 days efferent arteriolar colloid osmotic pressure 101028 2561
WKY efferent colloid osmotic pressure puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. blood molecular composition trait male  days 6 14.0 mmHg 1.0 2.45 p-aminohippurate analysis by liquid phase colorimetry renal efferent arteriole 0.0 PA IV 50mg/kg 15 days pie 100583 2479
MW efferent colloid osmotic pressure nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. blood molecular composition trait male  days 8 32.0 mmHg 2.0 5.66 micropuncture fluid collection 0.0 5/6 nephrectomy 28 days efferent arteriolar colloid osmotic pressure 101030 2561
MWF efferent colloid osmotic pressure castor oil Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4. blood molecular composition trait male 133.0 days-147.0 days 7 28.0 mmHg 2.87 7.6 servo-null micropipette transducer method 0.0 110115 3163
WKY efferent colloid osmotic pressure puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. blood molecular composition trait male  days 9 33.0 mmHg 1.0 3.0 p-aminohippurate analysis by liquid phase colorimetry renal efferent arteriole 0.0 PA IV 50mg/kg pie 100585 2479
WKY efferent colloid osmotic pressure controlled enalapril content drinking water (50 mg/l) (for 7 days) then puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. blood molecular composition trait male  days 8 29.0 mmHg 2.0 5.66 p-aminohippurate analysis by liquid phase colorimetry renal efferent arteriole 0.0 PA IV 50mg/kg pie 100586 2479
MWF efferent colloid osmotic pressure cyclosporine A (50 mg/kg/d) (for 7 days) Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4. blood molecular composition trait male 133.0 days-147.0 days 6 23.5 mmHg 0.78 1.9 servo-null micropipette transducer method 0.0 110116 3163
MWF/ZtmRrrc efferent colloid osmotic pressure control condition Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. blood molecular composition trait male 126.0 days 8 29.0 mmHg 2.12 6.0 servo-null micropipette transducer method renal efferent arteriole 0.0 100967 2541
WKY efferent colloid osmotic pressure 0.9% sodium chloride solution (3 ml) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. blood molecular composition trait male  days 9 29.0 mmHg 1.0 3.0 p-aminohippurate analysis by liquid phase colorimetry renal efferent arteriole 0.0 pie 100582 2479
MWF/Ztm efferent colloid osmotic pressure arterial catheter implantation and controlled hemorrhage Remuzzi A, etal., Kidney Int. 1988 Oct;34(4):481-6. doi: 10.1038/ki.1988.206. blood molecular composition trait male 112.0 days-147.0 days 8 29.1 mmHg 1.31 3.7 servo-null micropipette transducer method renal efferent arteriole 0.0 109223 3138
WKY efferent colloid osmotic pressure 0.9% sodium chloride solution (3 ml) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. blood molecular composition trait male  days 8 31.0 mmHg 1.0 2.83 p-aminohippurate analysis by liquid phase colorimetry renal efferent arteriole 0.0 pie 100584 2479
MW efferent colloid osmotic pressure nephrectomy (for 28 days) then enalapril (50 mg/l) (for 21 days) Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. blood molecular composition trait male  days 8 29.0 mmHg 1.0 2.83 micropuncture fluid collection 0.0 5/6 nephrectomy 28 days efferent arteriolar colloid osmotic pressure 101029 2561
MWF/Ztm efferent colloid osmotic pressure arterial catheter implantation and controlled hemorrhage Remuzzi A, etal., Kidney Int. 1988 Oct;34(4):481-6. doi: 10.1038/ki.1988.206. blood molecular composition trait female 126.0 days-147.0 days 8 28.3 mmHg 1.17 3.3 servo-null micropipette transducer method renal efferent arteriole 0.0 109224 3138
MWF efferent colloid osmotic pressure lacidipine (1 mg/kg/d) (for 7 days) and cyclosporine A (50 mg/kg/d) (for 7 days) Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4. blood molecular composition trait male 133.0 days-147.0 days 7 27.9 mmHg 2.57 6.8 servo-null micropipette transducer method 0.0 110117 3163